Search Available :
What Is Allogeneic Cell Therapy, And What’s Driving This
Published : 23-08-2023 - Duration : 01:52 - View : 5
Dailymotion : Download Convert to MP3
Description :
Biotechnology company Creative Medical Technology Holdings, Inc. seems to be witnessing success in the allogeneic cell therapy market.Â
In Q4 2022, the company – best known for its regenerative approach to immunotherapy, endocrinology, urology, gynecology and orthopedics – made a significant announcement regarding the successful development of an allogeneic cell line known as AlloStem™. AlloStem™ is a cell line that is derived from human perinatal tissue and includes a Master Cell Bank and a Drug Master File. Following FDA approval, the program – referred to as CELZ-201 – is now being utilized in an early type 1 diabetes clinical trial. It will continue to undergo development for the treatment of both type 1 and type 2 Diabetes.
Related Videos :
| Stem Cell Therapy for Type 1 Diabetes Benefits Treatment Explained Shenbagam Created : 27-03-2025 View : 1 |
| Cellbased therapy shows promise against Type1 diabetes 1breakingnewscom Created : 23-05-2022 View : 14 |
| Stem cell therapy potentially could treat Type 1 diabetes by helping patients pr Created : 01-12-2021 View : 25 |
| Stem Cell Therapy for Diabetes Type 1 and 2 Dr David Greene Arizona Created : 01-07-2020 View : 5 |
| PDF Medical Management of Type 1 Diabetes Kaufman Medical Management of Type 1 D Created : 09-11-2016 View : 6 |
